A new malaria vaccine that tackles the infection at a different stage to those currently on offer has been shown to be “safe ...

Scientists have unveiled a new tool for studying the highly variable traits that allow malaria parasites to stick to red ...

The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers ...

Using organ-on-a-chip technology, researchers successfully demonstrated that these antibodies prevent infected red blood cells from adhering to vessel walls, a key driver of severe malaria symptoms.

Scientists have unveiled a new tool for studying the highly variable traits that allow malaria parasites to stick to red blood cells and evade the immune system. The ability of the human malaria ...

The jab targets parasites after they pass through the liver and into the blood, which is the stage that causes symptoms ...

The results of a clinical tria l into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection ...

A new malaria vaccine is the first to offer "effective protection" against the blood-stage of the disease, a University of ...

Scientists have unveiled a new tool for studying the highly variable traits that allow malaria parasites to stick to red blood cells and evade the immune system. The ability of the human malaria ...